據報印度暫停批准進口中國製wifi設備 影響企業推出產品
《路透》引述行業消息人士報道,印度已連續數月暫停批准進口中國的wifi模組,導致戴爾(DELL.US)、HP(HPQ.US)、小米(01810.HK)、Oppo、Vivo及聯想(00992.HK)等大型廠商推遲在印度推出產品。
消息人士指,印度從中國進口任何搭載wifi模組的電子設備成品,包括藍牙音箱、無線耳機、智能手機、智能手錶及筆記型電腦都遭到延遲。而印度政府的無線規劃與協調部(WPC)最少由去年11月開始暫停批准中國進口電子設備成品wifi模組的申請,自此來自美國、中國及韓國企業的80多件申請案都在等待WPC批准,甚至一些成品來自中國的印度企業的申請也在等待批准。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.